Tag Archives: antibiotic

On Corker, ‘Super Bugs’ and a Senate-Approved Bill

Contained in the Food and Drug Administration bill that passed the U.S. Senate on Tuesday evening was language sponsored by Tennessee Sen. Bob Corker aimed at stimulating creation of new antibiotics to go after “super bugs.”
More from Bart Sullivan:
LeBonheur Children’s Research Hospital, the Department of Pediatrics at the University of Tennessee Health Science Center, St. Jude Children’s Research Hospital and the Regional Medical Center at Memphis strongly supported the Generating Antibiotic Incentives Now (GAIN) Act Corker introduced last October.
The bill allows companies to market qualifying antibiotics without concern for generic competition for five years longer than current law allows and facilitates certain aspects of the regulatory review process.
“Passage of the FDA bill shows that Congress can pass legislation through regular order and produce a good result for the American people,” Corker said. “I’m particularly pleased the legislation includes the GAIN Act. Antibiotic resistance is a growing issue that we must address now to properly prepare for the future.”
Antibiotic drugs are not as profitable as other drugs. The five-year non-compete provision provides an incentive for companies to invest in research. An increase in drug-resistant bacteria prompted Corker, a Republican, and Sen. Richard Blumenthal, D-Conn., to introduce the measure. A companion House bill passed by voice vote last week